Last Updated:2025/11/25
(pharmacology) A chimeric monoclonal antibody being developed for the treatment of malignant melanoma.
音声機能が動作しない場合はこちらをご確認ください
See correct answer
ecromeximab
Edit Histories(0)
Source Word